Safety & important information

mjn-SERAS is a Class IIa medical device with CE marking (2797) under EU Regulation 2017/745 (MDR), commercialized as Episeras in Europe.

Contraindications: The device must not be used in case of ear canal infection or skin lesions in the area of application.

Considerations: This medical device operates in conjunction with a mobile application available for Android and iOS devices.

Instructions for Use (IFU): Please refer to the official instructions available at:https://episeras.mjn.cat/ifu-language/

CPSP20103CAT

DemoSetup_V00

MJN Neuroserveis S.L.

CE 2797